| (19) |
 |
|
(11) |
EP 2 325 331 A8 |
| (12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
| (15) |
Correction information: |
|
Corrected version no 1 (W1 A1) |
| (48) |
Corrigendum issued on: |
|
03.08.2011 Bulletin 2011/31 |
| (43) |
Date of publication: |
|
25.05.2011 Bulletin 2011/21 |
| (22) |
Date of filing: 14.05.2005 |
|
| (51) |
International Patent Classification (IPC):
|
|
| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI
SK TR |
| (30) |
Priority: |
14.05.2004 US 709572
14.05.2004 US 709577
03.10.2004 US 522452 P
03.10.2004 US 522449 P
04.10.2004 US 522457 P
15.11.2004 US 522860 P
08.12.2004 US 593081 P
06.01.2005 US 593329 P
17.03.2005 US 662742 P
25.03.2005 US 665094 P
30.03.2005 US 666340 P
|
| (62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
05766834.5 / 1784501 |
| (71) |
Applicant: Rosetta Genomics Ltd |
|
76706 Rehovot (IL) |
|
| (72) |
Inventors: |
|
- Bentwich, Itzhak
Rosh Haayin (IL)
- Avniel, Amir
76706, Rehovot (IL)
- Karov, Yael
76706, Rehovot (IL)
- Aharonov, Ranit
76706, Rehovot (IL)
|
| (74) |
Representative: King, Hilary Mary |
|
Mewburn Ellis LLP
33 Gutter Lane
London
EC2V 8AS
London
EC2V 8AS (GB) |
|
| |
|
|
|
Remarks: |
|
The complete document including Reference Tables and the Sequence Listing can be downloaded
from the EPO website |
|
|
|
Remarks: |
|
This application was filed on 24-09-2010 as a divisional application to the application
mentioned under INID code 62. |
|
| (54) |
MicroRNAs and uses thereof |
(57) Described herein are novel polynucleotides associated with prostate and lung cancer.
The polynucleotides are miRNAs and miRNA precursors. Related methods and compositions
that can be used for diagnosis, prognosis, and treatment of those medical conditions
are disclosed. Also described herein are methods that can be used to identify modulators
of prostate and lung cancer.